The Effect of Exercise and nutrition on fatty liver disease

The assessment effect of aerobic training program on serum transaminases' levels and quality of life in patients with Non-Alcoholic Steatohepatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201104286319N1

Enrollment

Registered

2011-08-27

Start date

2010-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Alcoholic Steatohepatitis. Diseases of liver

Interventions

Intervention 1: Diet with aerobic training program. Intervention 2: Diet alone.

Treatment - Devices

Treatment - Other

Diet with aerobic training program

Diet alone

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18 to 65 years ; Approval Kbdchrb ultrasound; Increase 1.5 Equity serum enzyme alanine aminotransferase. Exclusion criteria: Hepatitis B2; Hepatitis C; Autoimmune hepatitis; CD; Wilson; 1a-deficient anti-trypsin; Hemochromatosis; thyroid disease; Ischemic heart disease; kidney failure; Drugs Hpatvtvksyk; More than 20 grams of alcohol per day.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
LDL. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;HDL. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;VLDL. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;TG. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;Weight. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: gram.;BMI. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Kg/M2.;ALT. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Unit U / L, a photometer methods.;AST. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Unit U / L, a photometer methods.;FBS. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;Insulin. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mIU/mL.;Chol. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;WC. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Cm.;WHpR. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: %.;WHtR. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: %.;HC. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Cm.;PBF. Timepoint: Before the intervention, two months after the start and end of three months. Method of meas	—

Measure

Time frame

LDL. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;HDL. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;VLDL. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;TG. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;Weight. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: gram.;BMI. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Kg/M2.;ALT. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Unit U / L, a photometer methods.;AST. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Unit U / L, a photometer methods.;FBS. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;Insulin. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mIU/mL.;Chol. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: mg/dL.;WC. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Cm.;WHpR. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: %.;WHtR. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: %.;HC. Timepoint: Before the intervention, two months after the start and end of three months. Method of measurement: Cm.;PBF. Timepoint: Before the intervention, two months after the start and end of three months. Method of meas

—

Secondary

Measure	Time frame
Height. Timepoint: Before the intervention, two months later and after three months. Method of measurement: Cm.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohsen Nematy

Mashhad University of Medical Sciences

NematyM@mums.ac.ir+98 51 1882 8569

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026